Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-08-05 Capital/Financing Update
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure and allocation details of a Qualified Institutions Placement (QIP) of equity shares by Morepen Laboratories Limited. It references regulatory provisions under SEBI ICDR Regulations and Companies Act, 2013, and details the approval of the issue closure, allocation of shares, and related procedural approvals by the QIP Committee. The document is an announcement of a capital raising event and related resolutions, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the capital issuance and allocation. Therefore, the document fits the category of Capital/Financing Update (CAP).
2024-08-05 English
Please find attached intimation of issuance of duplicate share certificates
Regulatory Filings
2024-08-02 English
Loss of Share Certificates
Regulatory Filings
2024-08-02 English
Please find enclosed outcome of the meeting of QIP Committee held on August 1, 2024.
Capital/Financing Update Classification · 95% confidence The document is an official communication from Morepen Laboratories Limited to stock exchanges regarding the opening of a Qualified Institutions Placement (QIP) of equity shares. It details the board and committee approvals, pricing, and regulatory compliance related to the issuance of new shares. The content focuses on capital raising activities, specifically the issuance of equity shares under SEBI regulations and company approvals. There are no financial statements or earnings data presented, nor is this a report or presentation. It is an announcement about a capital raising event and related approvals. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief notice or a report publication announcement but a substantive update on financing activity.
2024-08-01 English
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication from Morepen Laboratories Limited to stock exchanges regarding the opening of a Qualified Institutions Placement (QIP) of equity shares. It details the board and committee approvals, pricing, and regulatory compliance related to the issuance of new shares. The content focuses on capital raising activities, specifically the issuance of equity shares under SEBI regulations and company approvals. There are no financial statements or earnings data presented, nor is this a report or presentation. The document is an announcement about a capital raising event and related approvals, fitting the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing event, not merely a brief notice or report publication announcement.
2024-08-01 English
Please find enclosed financial statement of the company for the financial year 2024.
Regulatory Filings
2024-08-01 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.